Motility in Pseudomonas fluorescens with special reference to survival advantage and negative chemotaxis.
D000109:Acetylcholine / Q000494:pharmacology; D000654:Amobarbital / Q000494:pharmacology; D002633:Chemotaxis / Q000187:drug effects; D002701:Chloramphenicol / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003470:Culture Media; D001728:Dicumarol / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005407:Flagella / Q000502:physiology; D007210:Indoleacetic Acids / Q000494:pharmacology; D008124:Locomotion; D008858:Microscopy, Phase-Contrast; D009020:Morphine / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011549:Pseudomonas / Q000166:cytology / Q000254:growth & development / Q000502:physiology*; D011726:Pyridinium Compounds / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D013331:Strychnine / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology
D003470:Culture Media; D007210:Indoleacetic Acids; D010636:Phenols; D011726:Pyridinium Compounds; D013501:Surface-Active Agents; D010649:Phenylalanine; D002701:Chloramphenicol; D009020:Morphine; D001728:Dicumarol; D014508:Urea; D010830:Physostigmine; D000654:Amobarbital; D011796:Quinacrine; D013331:Strychnine; D003042:Cocaine; D000109:Acetylcholine; D004121:Dimethyl Sulfoxide